Eva Åkerblom

1.5k total citations
49 papers, 1.3k citations indexed

About

Eva Åkerblom is a scholar working on Hepatology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Eva Åkerblom has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 16 papers in Organic Chemistry and 14 papers in Infectious Diseases. Recurrent topics in Eva Åkerblom's work include Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (14 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Eva Åkerblom is often cited by papers focused on Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (14 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Eva Åkerblom collaborates with scholars based in Sweden and Belgium. Eva Åkerblom's co-authors include Ary Wolfgang Richter, U. Helena Danielson, Anja Sandström, Anders Hallberg, Anja Johansson, Gunnar Lindeberg, Mikael Dohlsten, Terje Kalland, Peter A. Lando and Thomas Gossas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

Eva Åkerblom

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Åkerblom Sweden	19	430	309	274	255	207	49	1.3k
W. Berthold Germany	16	619 1.4×	92 0.3×	317 1.2×	126 0.5×	270 1.3×	41	1.3k
Cristina Delgado United Kingdom	16	929 2.2×	155 0.5×	194 0.7×	31 0.1×	123 0.6×	40	1.7k
G. E. Francis United Kingdom	23	1.1k 2.5×	104 0.3×	269 1.0×	35 0.1×	336 1.6×	88	2.2k
Thorsten Kirschberg United States	14	665 1.5×	216 0.7×	37 0.1×	78 0.3×	77 0.4×	24	1.0k
Jinzi J. Wu United States	16	777 1.8×	156 0.5×	214 0.8×	45 0.2×	60 0.3×	41	1.2k
Selwyn J. Hurwitz United States	18	717 1.7×	64 0.2×	105 0.4×	127 0.5×	109 0.5×	75	1.6k
Thomas Schluep United States	24	1.2k 2.8×	179 0.6×	101 0.4×	690 2.7×	216 1.0×	47	2.6k
Frits H. Roerdink Netherlands	19	803 1.9×	80 0.3×	133 0.5×	33 0.1×	183 0.9×	28	1.4k
Ritu Shrestha United States	21	549 1.3×	174 0.6×	30 0.1×	89 0.3×	121 0.6×	36	1.3k
Jill E. Porter United States	6	298 0.7×	76 0.2×	171 0.6×	125 0.5×	91 0.4×	7	653

Countries citing papers authored by Eva Åkerblom

Since Specialization

Citations

This map shows the geographic impact of Eva Åkerblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Åkerblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Åkerblom more than expected).

Fields of papers citing papers by Eva Åkerblom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Åkerblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Åkerblom. The network helps show where Eva Åkerblom may publish in the future.

Co-authorship network of co-authors of Eva Åkerblom

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Åkerblom. A scholar is included among the top collaborators of Eva Åkerblom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Åkerblom. Eva Åkerblom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdurakhmanov, Eldar, Eva Åkerblom, Peter Brandt, et al.. (2018). Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold. European Journal of Medicinal Chemistry. 148. 453–464. 5 indexed citations

Abdurakhmanov, Eldar, Eva Åkerblom, Peter Brandt, et al.. (2016). Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease. Bioorganic & Medicinal Chemistry. 24(12). 2603–2620. 5 indexed citations

Gising, Johan, Eva Åkerblom, Richard Svensson, et al.. (2013). Achiral Pyrazinone-Based Inhibitors of the Hepatitis C Virus NS3 Protease and Drug-Resistant Variants with Elongated Substituents Directed Toward the S2 Pocket. Journal of Medicinal Chemistry. 57(5). 1790–1801. 19 indexed citations

Åkerblom, Eva, et al.. (2011). P2–P1′ macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis. Bioorganic & Medicinal Chemistry. 19(16). 4917–4927. 9 indexed citations

Gossas, Thomas, et al.. (2008). Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety. Bioorganic & Medicinal Chemistry. 16(6). 2955–2967. 18 indexed citations

Poliakov, Anton, Anja Sandström, Eva Åkerblom, & U. Helena Danielson. (2007). Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3. Journal of Enzyme Inhibition and Medicinal Chemistry. 22(2). 191–199. 11 indexed citations

Gossas, Thomas, et al.. (2007). Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15(12). 4057–4068. 45 indexed citations

Dahl, Göran, Anja Sandström, Eva Åkerblom, & U. Helena Danielson. (2007). Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3. FEBS Journal. 274(22). 5979–5986. 22 indexed citations

Åkerblom, Eva, Thomas Gossas, Yogesh Sabnis, et al.. (2006). Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15(3). 1448–1474. 41 indexed citations

10.

Sabnis, Yogesh, Thomas Gossas, Eva Åkerblom, et al.. (2005). Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3. Bioorganic & Medicinal Chemistry. 14(2). 544–559. 44 indexed citations

11.

Poliakov, Anton, Anja Johansson, Eva Åkerblom, et al.. (2004). Structure–activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors. Biochimica et Biophysica Acta (BBA) - General Subjects. 1672(1). 51–59. 16 indexed citations

12.

Johansson, Anja, Anton Poliakov, Eva Åkerblom, et al.. (2003). Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (Protease-Helicase/NTPase): A comparative study of different C-terminals. Bioorganic & Medicinal Chemistry. 11(12). 2551–2568. 85 indexed citations

13.

Johansson, Anja, Anton Poliakov, Eva Åkerblom, et al.. (2002). Tetrapeptides as potent protease inhibitors of hepatitis C virus full-Length NS3 (Protease-Helicase/NTPase). Bioorganic & Medicinal Chemistry. 10(12). 3915–3922. 36 indexed citations

14.

Johansson, Anja, Ina Hubatsch, Eva Åkerblom, et al.. (2001). Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain. Bioorganic & Medicinal Chemistry Letters. 11(2). 203–206. 27 indexed citations

15.

Åkerblom, Eva. (1998). Six new photolabile linkers for solid phase synthesis. 2. Coupling of various building blocks and photolytic cleavage. Molecular Diversity. 4(1). 53–69. 5 indexed citations

16.

Åkerblom, Eva, et al.. (1993). Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic crosslinker. Bioconjugate Chemistry. 4(6). 455–466. 8 indexed citations

17.

Kalland, Terje, Mikael Dohlsten, Peter A. Lando, et al.. (1993). Targeting of superantigens. Cell Biophysics. 22(1-3). 147–164. 5 indexed citations

18.

Öman, H., Eva Åkerblom, Walter Richter, & Sverker Johansson. (1992). Chemical and Physiological Properties of Polysucrose, a New Marker of Intestinal Permeability to Macromolecules. International Archives of Allergy and Immunology. 98(3). 220–226. 13 indexed citations

19.

Åkerblom, Eva, et al.. (1965). Alkyl Derivatives of 3-Amino-5-(2-furyl)-1,2,4-triazole. Part I. Synthesis of Alkylated 3-Amino-5-(2-furyl)-1,2,4-triazoles by Ring Closure of 1-Furoylaminoguanidines.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 19. 1135–1141. 1 indexed citations

20.

Åkerblom, Eva, et al.. (1965). Alkyl Derivatives of 3-Amino-5-(2-furyl)-1,2,4-triazole. Part III. A Spectrochemical Study of Tautomerism.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 19. 1191–1204. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact